Table 2.
Laerum 1995 [20] | Grenabo 1984 [21] | Kapoor 1985 [22] | ||||
Diclofenac 50 mg PO tds | Placebo tds | Indomethacin 25mg PO bd + 100 mg PR nocte | Placebo bd + nocte | Indomethacin 50 mg PR tds | Placebo tds | |
n | 41 | 39 | 37 | 41 | 13 | 13 |
Mean stone size | 78% <6 mm | 97% <6 mm | 2.9 mm | 2.8 mm | 3.4 mm | 3.1 mm |
Readmission Rate | 10% | 67% | 11% | 39% | 0% | 38% |
Mean stone passage rate | 68% at 3 weeks | 74% at 3 weeks | 59% at 1 week | 61% at 1 week | 11/13 | 10/13 |
Mean interval to passage | 3 days | 3.8 days | N/A | N/A | 3.4 days | 3.7 days |